Literature DB >> 20411786

Neurogenesis in substantia nigra of parkinsonian brains?

Oscar Arias-Carrión1, Elizabeth Yamada, Nils Freundlieb, Miriam Djufri, Lukas Maurer, Guido Hermanns, Bastian Ipach, Wei-Hua Chiu, Corinna Steiner, Wolfgang H Oertel, Günter U Höglinger.   

Abstract

The clinical motor dysfunction in Parkinson's disease is primarily the consequence of a progressive degeneration of dopaminergic neurons in the substantia nigra of the nigrostriatal pathway. The degeneration of this tract provokes a depletion of dopamine in the striatum, where it is required as a permissive factor for normal motor function. Despite intense investigations, no effective therapy is available to prevent the onset or to halt the progression of the neuronal cell loss. Therefore, recent years have seen research into the mechanisms of endogenous repair processes occurring in the adult brain, particularly in the substantia nigra. Neurogenesis occurs in the adult brain in a constitutive manner under physiological circumstances within two regions: the dentate gyrus of the hippocampus and the subventricular zone of the lateral ventricles. In contrast to these two so-called neurogenic areas, the remainder of the brain is considered to be primarily nonneurogenic in nature, implying that no new neurons are produced there under normal conditions. The occurrence of adult neurogenesis in the substantia nigra under the pathological conditions of Parkinson's disease, however, remains controversial. Here, we review the published evidence of whether adult neurogenesis exists or not within the substantia nigra, where dopaminergic neurons are lost in Parkinson's disease.

Entities:  

Mesh:

Year:  2009        PMID: 20411786     DOI: 10.1007/978-3-211-92660-4_23

Source DB:  PubMed          Journal:  J Neural Transm Suppl        ISSN: 0303-6995


  14 in total

1.  Natural toxins implicated in the development of Parkinson's disease.

Authors:  Mohamed Salama; Oscar Arias-Carrión
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

2.  Therapeutic application of neural stem cells and adult neurogenesis for neurodegenerative disorders: regeneration and beyond.

Authors:  Sarah E Latchney; Amelia J Eisch
Journal:  Eur J Neurodegener Dis       Date:  2012

3.  Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease.

Authors:  Chenyou Sun; Xiaoming Ou; Jerry M Farley; Craig Stockmeier; Steven Bigler; Roberta Diaz Brinton; Jun Ming Wang
Journal:  Curr Alzheimer Res       Date:  2012-05       Impact factor: 3.498

Review 4.  Adult neurogenesis in Parkinson's disease.

Authors:  Franz Marxreiter; Martin Regensburger; Jürgen Winkler
Journal:  Cell Mol Life Sci       Date:  2012-07-06       Impact factor: 9.261

5.  Nestin-positive/SOX2-negative cells mediate adult neurogenesis of nigral dopaminergic neurons in mice.

Authors:  Joshua E Albright; Iva Stojkovska; Abir A Rahman; Connor J Brown; Brad E Morrison
Journal:  Neurosci Lett       Date:  2016-01-20       Impact factor: 3.046

6.  The Chemical Molecule B355252 is Neuroprotective in an In Vitro Model of Parkinson's Disease.

Authors:  Nailya S Gliyazova; Gordon C Ibeanu
Journal:  Cell Mol Neurobiol       Date:  2015-12-09       Impact factor: 5.046

7.  Conditioning Against the Pathology of Parkinson's disease.

Authors:  Rehana K Leak
Journal:  Cond Med       Date:  2018-04-28

8.  Allopregnanolone reinstates tyrosine hydroxylase immunoreactive neurons and motor performance in an MPTP-lesioned mouse model of Parkinson's disease.

Authors:  Samuel O Adeosun; Xu Hou; Yun Jiao; Baoying Zheng; Sherry Henry; Rosanne Hill; Zhi He; Amar Pani; Patrick Kyle; Xiaoming Ou; Thomas Mosley; Jerry M Farley; Craig Stockmeier; Ian Paul; Steven Bigler; Roberta Diaz Brinton; Richard Smeyne; Jun Ming Wang
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

9.  Progenitor cell dynamics in the Newt Telencephalon during homeostasis and neuronal regeneration.

Authors:  Matthew Kirkham; L Shahul Hameed; Daniel A Berg; Heng Wang; András Simon
Journal:  Stem Cell Reports       Date:  2014-03-20       Impact factor: 7.765

10.  Hippocampal proliferation is increased in presymptomatic Parkinson's disease and due to microglia.

Authors:  Karlijn J Doorn; Benjamin Drukarch; Anne-Marie van Dam; Paul J Lucassen
Journal:  Neural Plast       Date:  2014-08-14       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.